Literature DB >> 22045771

Overcoming the age barrier in hematopoietic stem cell transplantation: progress, but still a long way to go.

Shin Mineishi.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 22045771     DOI： 10.1001/jama.2011.1612

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Inosine Monophosphate Dehydrogenase Pharmacogenetics in Hematopoietic Cell Transplantation Patients.

Authors:  Jeannine S McCune; Barry Storer; Sushma Thomas; Jožefa McKiernan; Rohan Gupta; Brenda M Sandmaier
Journal:  Biol Blood Marrow Transplant       Date:  2018-04-12       Impact factor: 5.742

Review 2.  Concise review: hematopoietic stem cell aging, life span, and transplantation.

Authors:  Gary Van Zant; Ying Liang
Journal:  Stem Cells Transl Med       Date:  2012-09-05       Impact factor: 6.940

3.  Recipient pretransplant inosine monophosphate dehydrogenase activity in nonmyeloablative hematopoietic cell transplantation.

Authors:  Meagan J Bemer; Linda J Risler; Brian R Phillips; Joanne Wang; Barry E Storer; Brenda M Sandmaier; Haichuan Duan; Brianne S Raccor; Michael J Boeckh; Jeannine S McCune
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-09       Impact factor: 5.742

4.  Costs of allogeneic hematopoietic cell transplantation using reduced intensity conditioning regimens.

Authors:  Nandita Khera; Amy Emmert; Barry E Storer; Brenda M Sandmaier; Edwin P Alyea; Stephanie J Lee
Journal:  Oncologist       Date:  2014-05-05

5.  Nonrelapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.

Authors:  Cara L McDermott; Brenda M Sandmaier; Barry Storer; Hong Li; Donald E Mager; Michael J Boeckh; Meagan J Bemer; Jennifer Knutson; Jeannine S McCune
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-06       Impact factor: 5.742

6.  Potential of whole-genome sequencing for determining risk and personalizing therapy: focus on AML.

Authors:  Uma Borate; Devin Absher; Harry P Erba; Boris Pasche
Journal:  Expert Rev Anticancer Ther       Date:  2012-10       Impact factor: 4.512
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.